Events & conferences in the Life Sciences industry
Below you find a list of upcoming events in the Life Sciences industry. We will be attending all events which are flagged with the Biotechgate / Venture Valuation logo.
If you are participating the conference and want to learn more, please contact us to schedule a meeting ››
Biotechgate Digital Partnering August 2025
Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.
Email: partnering@biotechgate.com
Representatives from Venture Valuation and Biotechgate will participate in Biotechgate Digital Partnering August 2025
LSX USA Congress
Boston USA
The LSX World Congress USA gathers leaders from the US biotech, medtech, and healthtech sectors to network, showcase innovations, and explore partnership opportunities. It offers a unique platform for CEOs, investors, and pharma executives to engage in meaningful discussions and collaborative sessions, shaping the future of healthcare technology.
Representatives from Venture Valuation and Biotechgate will participate in LSX USA Congress
8th Annual BioHealth Capital Region Investment Conference
Rockville USA
Join us for the 8th Annual BioHealth Capital Region Investor Conference taking place on September 25th, 2025, at the US Pharmacopeia. This highly anticipated in-person event brings together ambitious entrepreneurs and BioHealth companies with a diverse group of influential investors, offering funding opportunities ranging from pre-seed to Series A. Set in the heart of the thriving BioHealth Capital Region, this conference has a remarkable track record of cultivating success stories, leading to initial and follow-up financings, IPOs, and M&A activities. The conference maintains rigorous standards through a meticulous three-step selection process. First, companies submit detailed applications outlining their operations and financing needs. Next, selected companies create compelling online profiles for investor review. Finally, investors schedule exclusive meetings with the companies that capture their interest during the conference.
Pharma-Biotech Product & Company Valuation Workshop
An Introductory Course: Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.
Email: aswaan@celforpharma.com
Representatives from Venture Valuation and Biotechgate will participate in Pharma-Biotech Product & Company Valuation Workshop
12th Annual HealthTech Investment Forum
Basel Switzerland
The main programme for the 12th Annual HTIF will feature more than 7 hours of high-level speeches and panel discussions. In addition, there will be a global company showcase of 25+ presentations by established public, private, emerging, and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated parallel presentation tracks, including the Rising Stars – HealthTech Seed Companies Session, alongside virtual company showcases, which will be available on-demand during the virtual week. We anticipate about 250 delegates from Digital Health, MedTech/Device companies, banks, investors, and advisors with part of the audience participating virtually. The In-Person meetings will take place during the physical event on the 7th of October, while virtual meetings will be held from the 14th - 16th of October. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as the option to present slides using a screen share function and we will have a dedicated room for in-person meetings. We expect over 2000 meetings to be completed during SALSW. The conference will be held in the Central European Time (CEST) zone.
Representatives from Venture Valuation and Biotechgate will participate in 12th Annual HealthTech Investment Forum
25th Annual Biotech in Europe Forum
Basel Switzerland
Returning for its 25th Annual Edition, this established global bio-pharma industry event will address the key challenges and investment trends for 2025, with a strong focus on partnering, alliance management, and future prospects. Leading industry figures will contribute their insights through a series of panel discussions covering the broader market outlook, as well as innovation across different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage, and public companies with leading investors, analysts, money managers, and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners. The main programme for the 25th Annual BEF is spread throughout 2 days (8th - 9th of October) and will feature more than 15 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging, and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated parallel presentation tracks, including the Rising Stars – Biotech Seed Companies Session, alongside virtual company showcases, which will be available on-demand during the virtual week. We anticipate 650+ delegates will register for the forum from all sectors of Life Sciences, with the target audience being corporate and financial investors/partners, banks, and advisors, with part of the audience participating virtually.
Representatives from Venture Valuation and Biotechgate will participate in 25th Annual Biotech in Europe Forum
BioJapan
Yokohama Japan
BioJapan is Asia's premier bio-industry partnering event, comprising an Exhibition, Seminars, and Partnering sessions. As the world’s longest-running biotech exhibition, BioJapan, along with its two co-located events —Regenerative Medicine Japan, which accelerates R&D and commercialization in regenerative medicine, and healthTECH Japan, focusing on health management, diagnostics, and therapeutics through the integration of digital technology and life sciences— continues to drive innovation and collaboration in the industry.
Representatives from Venture Valuation and Biotechgate will participate in BioJapan
BioFuture 2025
New York City USA
BioFuture is where relentless therapeutic pioneers, innovators, and investors gather to assess and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions. At this year’s summit, we’ll explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. Be part of the discussions that will shape and transform the future of healthcare.
Representatives from Venture Valuation and Biotechgate will participate in BioFuture 2025
AusBiotech 2025 National Conference
Melbourne Australia
For decades, AusBiotech has united Australia’s life sciences sector, connecting people, ideas, and opportunities. Our flagship conference is the biggest week in biotech and life sciences, celebrating Australian life science innovations - from groundbreaking research to advanced medical technologies and therapies. As a super-connector event, it drives critical domestic conversations within our industry, boosting collaboration, informing policy, and creating long-term partnerships that enable Australia’s life sciences ecosystem to thrive. With expanding international attendance, the conference also underscores Australia’s growing opportunity to further amplify partnership potential and leverage global interest in our research, and the development and commercialisation of home-grown innovation. From 2025, this unparalleled gathering of industry leaders, innovators, entrepreneurs and researchers will be known as the AusBiotech International Conference. Built by our industry for our industry, AusBiotech 2025 is a platform to showcase innovation, forge international partnerships, and shape the future of life sciences. The quality of submissions we receive each year reflects the sector’s groundbreaking advancements.
Representatives from Venture Valuation and Biotechgate will participate in AusBiotech 2025 National Conference
World Orphan Drug Congress Europe 2025
Amsterdam Netherlands
The World Orphan Drug Congress Europe is the largest and most established event globally for orphan drugs and rare diseases. Join over 2,000 attendees, gain insights from 250+ industry leaders, and connect with over 130 exhibitors as we bring together experts across the entire orphan drug lifecycle, discussing areas including regulatory affairs and policy to global pricing and cutting-edge gene therapies. Our attendees represent the most senior individuals across the industry, including leaders in R&D, gene therapy, rare diseases, precision/personalised medicine, genetic disorders, patient advocacy and engagement, associations in ATMPs, investors, regulatory affairs professions, governmental bodies, and more... Join the World Orphan Drug Congress using code BTG20 to save an additional 20% off. Register here »
Representatives from Venture Valuation and Biotechgate will participate in World Orphan Drug Congress Europe 2025
BIO-Europe® 2025
Vienna Austria
BIO-Europe, Europe's premier biopharma partnering event, is heading to Vienna, Austria on November 3-5, 2025, followed by Digital Partnering on November 11-12. Drawing inspiration from Vienna's historic coffee houses where transformative ideas have flourished, this flagship industry gathering will connect over 5,500 life science professionals from 2,800+ companies across 60+ countries, facilitating approximately 29,000 one-to-one meetings. The event features comprehensive programming including startup initiatives, industry insights from thought leaders, and the Austrian networking pavilion LISA showcasing the country's thriving biotech ecosystem.
Representatives from Venture Valuation and Biotechgate will participate in BIO-Europe® 2025
Investival Showcase
London United Kingdom
Investival Showcase is your Ultimate Biotech, Healthtech and Medtech Networking & Pitching Event in London. With 8 incredible presenting stages for startup, growth stage and publicly listed Biotech, Healthtech, Medtech, TechBio, Digital Health and Deeptech companies.
Representatives from Venture Valuation and Biotechgate will participate in Investival Showcase
9th Annual Neuroscience Innovation Forum
San Francisco USA
Positioned at the beginning of JPM week, the NIF forum focuses on the latest developments across key areas of neuroscience, which are currently attracting record investor interest and deal flow. The main programme for the 9th Annual NIF will feature more than 8 hours of high-level keynotes and panel discussions addressing the important advances in therapeutic, neurotech, and diagnostics fields.
Representatives from Venture Valuation and Biotechgate will participate in 9th Annual Neuroscience Innovation Forum
Upcoming Life Sciences Events
- August 2025
- Biotechgate Digital Partnering August 2025
- September 2025
- Boston: LSX USA Congress
- Rockville: 8th Annual BioHealth Capital Region Investment Conference